Comparison of Katakakhadiradi kashay Ghan vati and oral Hypoglycemic drug in Prameha(Diabetes mallitus).
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2022/11/047595
- Lead Sponsor
- PDEAs College of Ayurved and Research Centre Sector no.-25, Nigdi, Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Sign and symptoms of Prameha
2.known case of Type-2 DM, NIDDM
3.Patient having HbA1C upto-10
4.Fasting blood sugar upto 250 mg% and post prandial blood sugar upto 350 mg%
5.patient taking Metformin+Glimepride drug since min 6 months
Exclusion Criteria
1.Juvenile Diabetes and Insulin Dependent Diabetes Mellitus (IDDM).
2.Patients with CKD and AKD.
3.Patients with acute complications Hyperglycemic & hypoglycemic coma,Ketoacidosis and related complication and Infections like gangrene.
4.Patients with chronic diabetic complications Nephropathy, Neuropathy and Retinopathy.
5.Pregnant & lactating women.
6.Patients suffering from all major systemic diseases IHD, TB, CA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate an efficacy of katakakhadiradi Ghan Vati 500mg twice a day before meal with koshnajala for 3 months as an add on effect to oral hypoglycemic agent in Prameha.Timepoint: 90 days with follow up on 15th,30th,45th,60th,75th,90th day
- Secondary Outcome Measures
Name Time Method 1.To compare and study the efficacy of Katakakhadiradi Ghan Vati for 3 months. <br/ ><br>2.To compare and study the efficacy of oral hypoglycemic agent for 3 months. <br/ ><br>2.To study the adverse effect if anyTimepoint: 90 days with follow up on 15th,30th,45th,60th,75th,90th day